The initial inventors of CanChew and CanChew+, the world’s first patented controlled-release cannabinoids
chewing gum have taken over their Intellectual Property into their new company – APIRx Pharmaceuticals.
APIRx Portfolio now includes 10 patents, 28 patent applications, over 35 Trademarks and close to 50 products
in various developmental stages.
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of
natural cannabinoid API’s (Active Pharmaceutical Ingredients), which are extracted from cannabis
plant material and purified to pharma grade.